Skip to main content

Table 7 Univariate and Multivariable analysis of factors potentially predictive of distant metastasis-free survival

From: High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis

Characteristics

Total(N)

Univariate analysis

Multivariate analysis

Hazard ratio (95% CI)

P value

Hazard ratio (95% CI)

P value

Age

2765

    

 <  = 60

1382

Reference

   

 > 60

1383

1.152 (0.831–1.625)

0.273

  

T stage

2759

    

T1

573

Reference

   

T2&T3&T4

2186

1.974 (1.164–2.977)

0.004

1.527 (0.822–2.312)

0.313

N stage

2753

    

N0

1374

Reference

   

N1&N2&N3

1378

2.712 (1.742–3.529)

 < 0.001

1.631 (1.042–2.636)

0.034

M stage

2649

    

M0

1913

Reference

   

M1

736

7.137 (3.785–12.465)

 < 0.001

5.024 (3.607–10.143)

 < 0.001

Pathologic stage

2746

    

Stage I

381

Reference

   

Stage II&Stage III&Stage IV

2365

3.539 (1.613–5.746)

0.013

1.463 (0.607–2.594)

0.815

ER status

2731

    

Negative

643

Reference

   

Positive

2088

0.703 (0.342–1.327)

0.019

0.820 (0.492–1.393)

0.314

PR status

2716

    

Negative

721

Reference

   

Positive

1995

0.524 (0.311–0.816)

 < 0.001

0.573 (0.249–1.214)

0.073

HER2 status

1843

    

Negative

1449

Reference

   

Positive

394

1.304 (0.801–2.024)

0.526

  

radiation_therapy

2679

    

No

1163

Reference

   

Yes

1516

0.649 (0.434–1.407)

0.434

  

HSPB1

2765

    

Low

1382

Reference

   

High

1383

1.614 (1.307–1.942)

0.045

  
  1. TMN stage was according to the seventh edition of the Guidelines for the American Journal of Critical Care. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor. Bold values indicate that p < 0.05